Diagnosis and therapy of multiple myeloma
The Korean Journal of Internal Medicine
;
: 263-273, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-35113
ABSTRACT
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first step is recognizing the symptoms and starting prompt treatment. Different strategies should be selected for young and elderly subjects. Young patients are commonly eligible for transplantation, which is now considered the standard approach for this setting, and various inductions therapies containing novel agents are available before transplantation. Elderly patients are usually not eligible for transplantation, and gentler approaches with new drugs combinations are used for their treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Pirazinas
/
Talidomida
/
Ácidos Borónicos
/
Factores de Edad
/
Trasplante de Células Madre
/
Factores Inmunológicos
/
Mieloma Múltiple
/
Antineoplásicos
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
The Korean Journal of Internal Medicine
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS